Ind Swift Ltd

NSE:INDSWFTLTD

Ind-Swift Ltd. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Chandigarh, Chandigarh. The firm operates in both domestic and export markets. The company is primarily engaged in the finished goods dosage and active pharmaceutical ingredients (APIs) and herbal products. The firm is also engaged in the hand sanitizer, face mask and personal protective equipment (PPE) kit market. The company operates through various divisions, such as Herba Plus Division, Noble Division, Nova Division, Ethical Division, Generic Division, Institution Division and Proposed Division. Its Herba Plus Division is engaged in the manufacturing of ayurvedic and pharmaceutical products, such as general category formulations, beta lactam, steroids and hormones, cephalosporins, oncological, soft gelatin capsules, and herbal and nutraceuticals. Its Noble Division produces various products, such as Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin and Stemin Forte.